Press release
Atopic Dermatitis - Drug Pipeline Landscape, 2023 | Allakos, Inc., Amgen, Amtixbio Co Ltd, Amytrx Therapeutics, Inc
Request for a PDF sample copy of report: https://www.globalinsightservices.com/request-sample/GIS31002
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may cra*ck and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness.
Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger an immune system response that causes the inflamed skin and other symptoms.
Read more about Atopic Dermatitis - Drug Pipeline Landscape here: https://www.globalinsightservices.com/reports/atopic-dermatitis-drug-pipeline-landscape-2022/
Report Highlights
Global Insight Service's, Atopic Dermatitis - Drug Pipeline Landscape, 2022 report provides an overview of the Atopic Dermatitis pipeline drugs. This report covers detailed insights on Atopic Dermatitis drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Atopic Dermatitis pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.
Some of the key players involved in development of Atopic Dermatitis therapeutics are :
Key Players
• 3SBio Inc
• AbbVie
• Aclaris Therapeutics, Inc.
• Akaal Pharma Pty Ltd
• Akesobio Australia Pty Ltd
• Allakos, Inc.
• Amgen
• Amtixbio Co Ltd
• Amytrx Therapeutics, Inc
• AOBiome LLC
• Arcutis Biotherapeutics, Inc.
• Arena Pharmaceuticals
• Arjil Pharmaceuticals LLC
• Asana BioSciences
• ASLAN Pharmaceuticals
• AstraZeneca
• Atrapos Therapeutics LLC
• Avixgen Inc
Buy this report: https://www.globalinsightservices.com/checkout/single_user/GIS31002/
With Global Insight Services, you receive:
• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Excel data pack included with all report purchases
• Robust and transparent research methodology
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Atopic Dermatitis - Drug Pipeline Landscape, 2023 | Allakos, Inc., Amgen, Amtixbio Co Ltd, Amytrx Therapeutics, Inc here
News-ID: 2921684 • Views: …
More Releases from Global Insight Services
Public Key Infrastructure (PKI) Market to Reach $12.6 Billion by 2034 With 9.9% …
The Public Key Infrastructure (PKI) Market plays a critical role in the global cybersecurity landscape, enabling organizations to secure electronic communications and digital transactions. By providing a framework for encryption, authentication, and digital certificates, PKI ensures trust, confidentiality, and data integrity across industries. From banking and government services to healthcare and manufacturing, PKI has become essential in a world increasingly reliant on digital technologies. As enterprises accelerate digital transformation, the…
Fish Sauce Market Grows From $2.2 Billion in 2024 Amid Rising Demand for Authent …
The Fish Sauce Market has long been an integral part of Asian culinary traditions, particularly in countries such as Vietnam and Thailand. Made from fermented fish and salt, this flavorful condiment has been a staple for centuries, adding depth and umami to countless dishes. Today, the Fish Sauce Market is expanding far beyond its roots, finding its way into kitchens across North America, Europe, and beyond. With the rising global…
Breath Analyzer Market Is Anticipated To Expand From $4.1 Billion In 2024 To $9. …
Market Overview
The Breath Analyzer Market is gaining remarkable traction worldwide as demand for alcohol detection and health monitoring tools continues to rise. These devices, designed to measure blood alcohol content (BAC) through breath samples, have become indispensable in law enforcement, healthcare, and workplace safety. The market is projected to expand from $4.1 billion in 2024 to $9.8 billion by 2034, growing at a CAGR of 9.1%. This growth is fueled…
Web Hosting Services Market Is Anticipated To Expand From $83.99 Billion In 2024 …
Market Overview
The Web Hosting Services Market is evolving rapidly as businesses and individuals continue to strengthen their online presence. Hosting services act as the backbone of the digital economy, providing the infrastructure that powers websites, e-commerce platforms, and digital applications. The industry covers a wide range of offerings, including shared hosting, dedicated hosting, virtual private servers (VPS), and cloud hosting. Each solution caters to different customer needs, from small businesses…
More Releases for Atopic
Atopic Dermatitis Market Trends That Will Shape the Next Decade: Insights from P …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
How Large Will the Atopic Dermatitis Market Size By 2025?
The market size for atopic dermatitis has seen significant expansion in the past few years. This expansion is anticipated to continue, with the market size increasing from $8.61 billion in 2024 to $9.96 billion in 2025, exhibiting a compound annual growth rate (CAGR) of…
Atopic Dermatitis Pipeline Outlook Report 2024
DelveInsight's, "Atopic Dermatitis Pipeline Insight 2024" report provides comprehensive insights about 100+ companies and 110+ pipeline drugs in the Atopic Dermatitis pipeline landscape. It covers the pipeline drug profiles, including Atopic Dermatitis clinical trials and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from the Atopic Dermatitis Pipeline…
Advanced Therapy Revolutionizes Atopic Dermatitis Market Prospects
The atopic dermatitis market size is expected to be valued at USD 15.42 Billion in 2024 and reach USD 30.5 Billion by 2029, growing at a CAGR of 14.5 % from 2024 to 2029.
Atopic dermatitis, known as eczema, is a prevalent skin condition marked by red, inflamed, and itchy skin. It is a chronic condition commonly seen in children but can also impact adults. Atopic dermatitis is thought to result…
Atopic Dermatitis - Drug Pipeline Landscape, 2023
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may crak and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness. Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger…
Atopic Dermatitis - Drug Pipeline Landscape, 2022
Atopic dermatitis (eczema) is a condition that causes dry, itchy and inflamed skin. It's characterized by inflamed skin that may cr*ck and release a clear fluid when scratched. Eczema damages the skin barrier function that makes skin more sensitive and more prone to infection and dryness.
Atopic dermatitis is caused by a combination of immune system activation, genetics, environmental triggers and stress. A weak skin barrier function might also trigger an…
Atopic Dermatitis (Atopic Eczema) Treatment Market Business Growth And Industry …
Precision Business Insights published a research report on “Atopic Dermatitis (Atopic Eczema) Treatment Market by Drug type (Corticosteroids, Calcineurin Inhibitors, Immunosuppressants, Phosphodiesterase type 4 (PDE-4) Inhibitors, Antibiotics, Antihistamines, Emollients), Route of administration (Oral, Topical, Parenteral), Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography - Global/Region/Country Forecast to 2027”.
In people who suffer from atopic dermatitis, allergies play a big influence. When the patient is exposed to…
